Cara Therapeutics (CARA) Buy Rating Reaffirmed at Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript August 7, 2023 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00058 EPS, expectations were $0.56. Operator: Thank you for standing by, and welcome to Cara Therapeutics’ Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. […]
Cara Therapeutics (NASDAQ:CARA – Get Free Report) had its target price lowered by research analysts at Piper Sandler from $13.00 to $12.00 in a research note issued on Tuesday, FlyOnTheWall reports. Piper Sandler’s target price would suggest a potential upside of 313.79% from the company’s current price. Other equities research analysts also recently issued reports […]
Cara Therapeutics Stock (NASDAQ:CARA), Quotes and News Summary benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.